Ramune Jacobsen1,2, Steffen U Thorsen3,4, Arieh S Cohen5, Marika Lundqvist5, Peder Frederiksen6, Christian B Pipper7, Flemming Pociot3,4, Lau C Thygesen8, Alberto Ascherio9, Jannet Svensson3,4, Berit L Heitmann6,10,8,11,12. 1. Research Unit for Dietary Studies at The Parker Institute, Copenhagen University Hospital, Bispebjerg og Frederiksberg, Nordre Fasanvej 57, Hovedvejen, Entrance 5, Ground Floor, 2000, Frederiksberg, Denmark. ramune.jacobsen@regionh.dk. 2. The Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospital, The Capital Region, Frederiksberg, Denmark. ramune.jacobsen@regionh.dk. 3. Copenhagen Diabetes Research Center (CPH-DIRECT), Department of Paediatrics, Herlev Hospital, University of Copenhagen, Herlev, Denmark. 4. Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 5. Department of Congenital Disorders, Statens Serum Institute, Copenhagen, Denmark. 6. Research Unit for Dietary Studies at The Parker Institute, Copenhagen University Hospital, Bispebjerg og Frederiksberg, Nordre Fasanvej 57, Hovedvejen, Entrance 5, Ground Floor, 2000, Frederiksberg, Denmark. 7. Department of Public Health, Section of Biostatistics, University of Copenhagen, Copenhagen, Denmark. 8. National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark. 9. Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA, USA. 10. The Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospital, The Capital Region, Frederiksberg, Denmark. 11. The Boden Institute of Obesity, Nutrition Exercise and Eating Disorders, Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia. 12. Institute of Public Health, University of Copenhagen, Copenhagen, Denmark.
Abstract
AIMS/HYPOTHESIS: The aim of this work was to assess whether neonatal levels of 25-hydroxyvitamin D (25(OH)D) are associated with risk of developing type 1 diabetes before the age of 18 years. METHODS: Two large-scale studies with different designs-a case-cohort and a case-control-were conducted using Danish national register data and biobank material. Weighted Cox regression and conditional logistic regression were used to calculate HRs and ORs, respectively. The concentration of 25(OH)D was assessed from neonatal dried blood spots using highly sensitive liquid chromatography-tandem mass spectrometry. Quintiles of 25(OH)D3 were used in the main analyses. RESULTS: The case-cohort study included 912 type 1 diabetes cases and 2866 individuals without type 1 diabetes born in Denmark between 1981 and 2002 and followed up until the end of 2012. The case-control study included 527 matched case-control pairs born between 1981 and 1999 and followed up until May 2004. Both studies found no association between 25(OH)D3 levels and later risk of developing type 1 diabetes. The neonatal total 25(OH)D levels in the studies were low: 46% (case-cohort study) and 51% (case-control study) of individuals had 25(OH)D levels <25 nmol/l. CONCLUSIONS/ INTERPRETATION: Our two large-scale national studies showed that 25(OH)D3 levels around the time of birth were not associated with later type 1 diabetes risk. Whether higher levels of 25(OH)D3 during pregnancy, acquired by higher doses of supplementation than are recommended today in most countries, could protect the offspring against type 1 diabetes cannot be ruled out by the present studies.
AIMS/HYPOTHESIS: The aim of this work was to assess whether neonatal levels of 25-hydroxyvitamin D (25(OH)D) are associated with risk of developing type 1 diabetes before the age of 18 years. METHODS: Two large-scale studies with different designs-a case-cohort and a case-control-were conducted using Danish national register data and biobank material. Weighted Cox regression and conditional logistic regression were used to calculate HRs and ORs, respectively. The concentration of 25(OH)D was assessed from neonatal dried blood spots using highly sensitive liquid chromatography-tandem mass spectrometry. Quintiles of 25(OH)D3 were used in the main analyses. RESULTS: The case-cohort study included 912 type 1 diabetes cases and 2866 individuals without type 1 diabetes born in Denmark between 1981 and 2002 and followed up until the end of 2012. The case-control study included 527 matched case-control pairs born between 1981 and 1999 and followed up until May 2004. Both studies found no association between 25(OH)D3 levels and later risk of developing type 1 diabetes. The neonatal total 25(OH)D levels in the studies were low: 46% (case-cohort study) and 51% (case-control study) of individuals had 25(OH)D levels <25 nmol/l. CONCLUSIONS/ INTERPRETATION: Our two large-scale national studies showed that 25(OH)D3 levels around the time of birth were not associated with later type 1 diabetes risk. Whether higher levels of 25(OH)D3 during pregnancy, acquired by higher doses of supplementation than are recommended today in most countries, could protect the offspring against type 1 diabetes cannot be ruled out by the present studies.
Entities:
Keywords:
Denmark; Gestation; Registers; Type 1 diabetes; Vitamin D
Authors: John J McGrath; Darryl W Eyles; Carsten B Pedersen; Cameron Anderson; Pauline Ko; Thomas H Burne; Bent Norgaard-Pedersen; David M Hougaard; Preben B Mortensen Journal: Arch Gen Psychiatry Date: 2010-09
Authors: M E Miettinen; L Reinert; L Kinnunen; V Harjutsalo; P Koskela; H-M Surcel; C Lamberg-Allardt; J Tuomilehto Journal: Diabetologia Date: 2012-01-20 Impact factor: 10.122
Authors: Darryl Eyles; Cameron Anderson; Pauline Ko; Alun Jones; Andrew Thomas; Thomas Burne; Preben Bo Mortensen; Bent Nørgaard-Pedersen; David Michael Hougaard; John McGrath Journal: Clin Chim Acta Date: 2009-02-14 Impact factor: 3.786
Authors: Giuseppe Saggese; Francesco Vierucci; Flavia Prodam; Fabio Cardinale; Irene Cetin; Elena Chiappini; Gian Luigi De' Angelis; Maddalena Massari; Emanuele Miraglia Del Giudice; Michele Miraglia Del Giudice; Diego Peroni; Luigi Terracciano; Rino Agostiniani; Domenico Careddu; Daniele Giovanni Ghiglioni; Gianni Bona; Giuseppe Di Mauro; Giovanni Corsello Journal: Ital J Pediatr Date: 2018-05-08 Impact factor: 2.638
Authors: Steffen U Thorsen; Karl Mårild; Sjurdur F Olsen; Klaus K Holst; German Tapia; Charlotta Granström; Thorhallur I Halldorsson; Arieh S Cohen; Margaretha Haugen; Marika Lundqvist; Torild Skrivarhaug; Pål R Njølstad; Geir Joner; Per Magnus; Ketil Størdal; Jannet Svensson; Lars C Stene Journal: Am J Epidemiol Date: 2018-06-01 Impact factor: 4.897
Authors: German Tapia; Karl Mårild; Sandra R Dahl; Nicolai A Lund-Blix; Marte K Viken; Benedicte A Lie; Pål R Njølstad; Geir Joner; Torild Skrivarhaug; Arieh S Cohen; Ketil Størdal; Lars C Stene Journal: Diabetes Care Date: 2019-01-28 Impact factor: 19.112